MedTrace Logo

Metformin Versus Insulin in the Treatment of Gestational Diabetes Mellitus

NCT01087866 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2010-03-16

No results posted yet for this study

Summary

The purpose of this study is to determine if metformin therapy prevents fetal macrosomy in gestational diabetes mellitus to the same extent as insulin therapy.

Conditions

  • Gestational Diabetes Mellitus

Interventions

DRUG

Metformin

DRUG

Insulin

Sponsors & Collaborators

  • University of Oulu

    lead OTHER

Principal Investigators

  • Hilkka Ijas, MD · Oulu University Hospital

  • Tytti Raudaskoski, MD,PhD · Oulu University Hospital

  • Marja Vaarasmaki, MD, PhD · Oulu University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-06-30
Primary Completion
2009-08-31
Completion
2009-10-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01087866 on ClinicalTrials.gov